Advanced Enzyme Technologies Limited (NSE: ADVENZYMES), ISIN INE837H01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ADVENZYMES last traded at ₹311.60 (+0.34%), with a 52-week range of ₹251.90 to ₹419.80 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 43.24%, FIIs 26.71%, DIIs 4.78%, mutual funds 1.82%.
EquiSense Score (ECS): 87/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.